COR Stock Summary and Trading Ideas (Cencora | NYSE:COR)

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Cencora trades on the NYSE stock market under the symbol COR.

As of May 10, 2024, COR stock price climbed to $224.60 with 868,966 million shares trading.

COR has a beta of 0.20, meaning it tends to be less sensitive to market movements. COR has a correlation of 0.02 to the broad based SPY ETF.

COR has a market cap of $44.79 billion. This is considered a Large Cap stock.

Last quarter Cencora reported $68 billion in Revenue and $3.80 earnings per share. This fell short of revenue expectation by $-2 billion and exceeded earnings estimates by $.11.

The top ETF exchange traded funds that COR belongs to (by Net Assets): VTI, VOO, VO, SPY, COWZ.

COR support price is $221.74 and resistance is $226.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COR stock will trade within this expected range on the day.